Medicine
Cefuroxime 250 mg tablet
Cefuroxime 250 mg tablet is a generic prescription medicine for oral use, made by 13 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Cefuroxime
- Brand
- Sold under the generic name
- Strength
- 250 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 20 tablets, 60 tablets and 37 more
- Manufacturers
- Ascend LaboratoriesIndiaAurobindo PharmaIndiaA-S Medication SolutionsPD-Rx PharmaceuticalsGolden State Medical SupplyNorthStar RxProficient RxRedpharm DrugRising Pharma HoldingsAmerican Health Packaging
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DC02 Cefuroxime
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 29 March 2006
- Identifiers
- RxCUI 309097, 309098, 309095DailyMed set ID a84ac4ed-c268-4e9f-9df8-256e0a64cd16, 8c3c1c85-cbce-66e2-e053-2a95a90a94fe, bcf7870a-7e45-4ae1-a9b4-457e4781886a +18NDC 43063-623, 68071-4947, 50090-6999 +18Application ANDA065308, ANDA065496
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 bottle | 67877-215-01 | Ascend LaboratoriesIndia | 1 December 2010 |
| 20 tablet, film coated in 1 bottle | 67877-215-20 | Ascend LaboratoriesIndia | 1 December 2010 |
| 60 tablet, film coated in 1 bottle | 67877-215-60 | Ascend LaboratoriesIndia | 1 December 2010 |
| 30 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 67877-215-84 | Ascend LaboratoriesIndia | 1 December 2010 |
| 20 tablet in 1 bottle | 65862-699-20 | Aurobindo PharmaIndia | 29 March 2006 |
| 60 tablet in 1 bottle | 65862-699-60 | Aurobindo PharmaIndia | 29 March 2006 |
| 20 tablet, film coated in 1 bottle | 57237-058-20 | Rising Pharma Holdings | 29 March 2006 |
| 60 tablet, film coated in 1 bottle | 57237-058-60 | Rising Pharma Holdings | 29 March 2006 |
| 20 tablet in 1 bottle | 50090-0781-0 | A-S Medication Solutions | 28 November 2014 |
| 14 tablet in 1 bottle | 50090-0781-3 | A-S Medication Solutions | 7 October 2025 |
| 20 tablet in 1 bottle | 50090-0782-0 | A-S Medication Solutions | 28 November 2014 |
| 14 tablet in 1 bottle | 50090-0782-1 | A-S Medication Solutions | 19 January 2026 |
| 20 tablet, film coated in 1 bottle | 50090-2158-0 | A-S Medication Solutions | 21 October 2015 |
| 14 tablet, film coated in 1 bottle | 50090-2158-3 | A-S Medication Solutions | 21 October 2015 |
| 20 tablet, film coated in 1 bottle | 50090-2159-0 | A-S Medication Solutions | 21 October 2015 |
| 14 tablet, film coated in 1 bottle | 50090-2159-1 | A-S Medication Solutions | 26 August 2024 |
| 20 tablet in 1 bottle | 50090-6999-0 | A-S Medication Solutions | 27 December 2023 |
| 14 tablet in 1 bottle | 50090-6999-1 | A-S Medication Solutions | 3 January 2024 |
| 20 tablet in 1 bottle | 50090-7095-0 | A-S Medication Solutions | 27 February 2024 |
| 14 tablet in 1 bottle | 50090-7095-3 | A-S Medication Solutions | 20 February 2024 |
| 20 tablet in 1 bottle | 50090-7667-0 | A-S Medication Solutions | 6 October 2025 |
| 60 tablet in 1 bottle | 50090-7667-1 | A-S Medication Solutions | 6 October 2025 |
| 14 tablet in 1 bottle, plastic | 43063-623-14 | PD-Rx Pharmaceuticals | 10 October 2024 |
| 20 tablet in 1 bottle, plastic | 43063-623-20 | PD-Rx Pharmaceuticals | 27 October 2015 |
| 14 tablet, film coated in 1 bottle, plastic | 43063-656-14 | PD-Rx Pharmaceuticals | 8 July 2024 |
| 20 tablet, film coated in 1 bottle, plastic | 43063-656-20 | PD-Rx Pharmaceuticals | 5 February 2016 |
| 20 tablet, film coated in 1 bottle, plastic | 43063-657-20 | PD-Rx Pharmaceuticals | 5 February 2016 |
| 60 tablet, film coated in 1 bottle, plastic | 43063-657-60 | PD-Rx Pharmaceuticals | 18 December 2019 |
| 20 blister pack in 1 box, unit-dose / 1 tablet, film coated in 1 blister pack | 60687-272-94 | American Health Packaging | 23 May 2018 |
| 30 tablet in 1 blister pack | 67046-1307-3 | Coupler | 23 January 2025 |
| 20 tablet, film coated in 1 bottle | 51407-333-20 | Golden State Medical Supply | 29 January 2021 |
| 60 tablet, film coated in 1 bottle | 51407-333-60 | Golden State Medical Supply | 29 January 2021 |
| 2 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 0904-7542-10 | Major Pharmaceuticals | 25 August 2025 |
| 20 tablet in 1 bottle | 16714-400-01 | NorthStar Rx | 29 March 2006 |
| 60 tablet in 1 bottle | 16714-400-02 | NorthStar Rx | 29 March 2006 |
| 2 tablet, film coated in 1 bottle | 68071-4947-2 | NuCare Pharmaceuticals,Inc | 26 June 2019 |
| 20 tablet, film coated in 1 bottle | 63187-991-20 | Proficient Rx | 1 March 2018 |
| 60 tablet, film coated in 1 bottle | 63187-991-60 | Proficient Rx | 1 December 2010 |
| 20 tablet, film coated in 1 bottle | 67296-2265-2 | Redpharm Drug | 29 March 2006 |
| 14 tablet, film coated in 1 bottle | 67296-2265-4 | Redpharm Drug | 29 March 2006 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 19 October 1983 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Cefuroxime
Clinical summary
Cefuroxime is a cephalosporin antibacterial indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in diseases. MedsAcross supplies Cefuroxime for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CefuroximeFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cefuroxime and Dextrose prescribing information (B. Braun Medical) · U.S. National Library of Medicine, DailyMed
Need Cefuroxime 250 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.